Attached files

file filename
EX-99.2 - EXHIBIT 99.2 - Maquia Capital Acquisition Corptm216812d21_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - Maquia Capital Acquisition Corptm216812d21_ex99-1.htm
EX-10.4 - EXHIBIT 10.4 - Maquia Capital Acquisition Corptm216812d21_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - Maquia Capital Acquisition Corptm216812d21_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - Maquia Capital Acquisition Corptm216812d21_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - Maquia Capital Acquisition Corptm216812d21_ex10-1.htm
EX-4.1 - EXHIBIT 4.1 - Maquia Capital Acquisition Corptm216812d21_ex4-1.htm
EX-3.1 - EXHIBIT 3.1 - Maquia Capital Acquisition Corptm216812d21_ex3-1.htm
EX-1.1 - EXHIBIT 1.1 - Maquia Capital Acquisition Corptm216812d21_ex1-1.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported):  May 4, 2021

 

Maquia Capital Acquisition Corporation

(Exact name of registrant as specified in its charter)

 

Delaware  001-40380  85-4283150
(State or other jurisdiction
of incorporation)
  (Commission File Number)  (IRS Employer
Identification No.)

 

50 Biscayne Boulevard, Suite 2406

Miami, FL 33132

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: (305) 608-1395

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  Trading Symbol(s)  Name of each exchange on
which registered
Units, each consisting of one share of Class A Common Stock, one Right and one-half of one Redeemable Warrant  MAQCU  The Nasdaq Stock Market LLC
       
Class A Common Stock, par value $0.0001 per share  MAQC  The Nasdaq Stock Market LLC
       
Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50  MAQCW  The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company þ

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 1.01. Entry into a Material Definitive Agreement.

 

On May 7, 2021, Maquia Capital Acquisition Corporation, a Delaware corporation (the “Company”), consummated its initial public offering (the “IPO”) of 16,000,000 units (the “Units”). Each Unit consists of one share of Class A common stock of the Company, par value $0.0001 per share (“Class A Common Stock”) and one-half of one redeemable warrant of the Company (“Warrant”), with each whole Warrant entitling the holder thereof to purchase one share of Class A Common Stock for $11.50 per share. The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $160,000,000. The Company granted the underwriters in the IPO a 45-day option to purchase up to 2,400,000 additional Units solely to cover over-allotments, if any.

 

In connection with the IPO, the Company entered into the following agreements, forms of which were previously filed as exhibits to the Company’s Registration Statement on Form S-1 (File No. 333-253167) for the IPO, originally filed with the U.S. Securities and Exchange Commission on February 16, 2021 (as amended, the “Registration Statement”):

 

  An Underwriting Agreement, dated May 4, 2021, by and between the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc., a copy of which is attached as Exhibit 1.1 hereto and incorporated herein by reference.

 

  A Warrant Agreement, dated May 4, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent, a copy of which is attached as Exhibit 4.1 hereto and incorporated herein by reference.

 

  A Letter Agreement, dated May 4, 2021, by and among the Company, its officers and directors and the Company’s sponsor, ARC Global Investments LLC (the “Sponsor”), a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.

 

  An Investment Management Trust Agreement, dated May 4, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, a copy of which is attached as Exhibit 10.2 hereto and incorporated herein by reference.

 

  A Registration Rights Agreement, dated May 4, 2021, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.3 hereto and incorporated herein by reference.

 

  A Unit Subscription Agreement, dated May 4, 2021 (the “Unit Subscription Agreement”), by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.4 hereto and incorporated herein by reference.

  

Item 3.02. Unregistered Sales of Equity Securities.

 

Simultaneously with the closing of the IPO, pursuant to the Unit Subscription Agreement, the Company completed the private sale of 551,000 units (the “Private Placement Units”) to the Sponsor at a purchase price of $10.00 per Private Placement Unit, generating gross proceeds to the Company of $5,510,000. The Private Placement Units are identical to the Units sold as part of the Units in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.

 

2

 

 

Item 5.03. Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.

 

On May 4, 2021, in connection with the IPO, the Company filed its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware, effective the same day. The terms of the Amended and Restated Certificate of Incorporation are set forth in the Registration Statement and are incorporated herein by reference. A copy of the Amended and Restated Certificate of Incorporation is attached as Exhibit 3.1 hereto and incorporated herein by reference. 

 

Item 8.01. Other Events.

 

A total of $162,400,000, comprised of $156,890,000 of the proceeds from the IPO (which amount includes $4,800,000 of the underwriters’ deferred discount) and $5,510,000 of the proceeds of the sale of the Private Placement Units, was placed in a U.S.-based trust account, maintained by Continental Stock Transfer & Trust Company, acting as trustee. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its taxes (less up to $100,000 interest to pay dissolution expenses), the funds held in the trust account will not be released from the trust account until the earliest of (i) the completion of the Company’s initial business combination, (ii) the redemption of any of the Company’s public shares properly submitted in connection with a stockholder vote to amend the Company’s Amended and Restated Certificate of Incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial business combination or to redeem 100% of its public shares if the Company does not complete its initial business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if extended) or (B) with respect to any other provision relating to stockholders’ rights or pre-initial business combination activity, and (iii) the redemption of all of the Company’s public shares if it has not completed the initial business combination within 12 months from the closing of the IPO (or up to 18 months from the closing of the IPO if extended), subject to applicable law. 

 

On May 4, 2021, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.

 

On May 7, 2021, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2 to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

The following exhibits are being filed herewith:

 

Exhibit No.   Description
1.1   Underwriting Agreement, dated May 4, 2021, by and between the Company and Kingswood Capital Markets, division of Benchmark Investments, Inc.
     
3.1   Amended and Restated Certificate of Incorporation.
     
4.1   Warrant Agreement, dated May 4, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent.
     
10.1   Letter Agreement, dated May 4, 2021, by and among the Company, its officers and directors, Kingswood Capital Markets, division of Benchmark Investments, Inc., and the Sponsor.
     
10.2   Investment Management Trust Agreement, dated May 4, 2021, by and between the Company and Continental Stock Transfer & Trust Company, as trustee.
     
10.3   Registration Rights Agreement, dated May 4, 2021, by and among the Company and certain security holders.
     
10.4   Unit Subscription Agreement, dated May 4, 2021, by and between the Company and the Sponsor.
     
99.1   Press Release, dated May 4, 2021.
     
99.2   Press Release, dated May 7, 2021.

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: May 10, 2021

  MAQUIA CAPITAL ACQUISITION CORPORATION
   
  By: /s/ Jeronimo Peralta
   

Jeronimo Peralta

   

Chief Financial Officer

 

4